Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6968
Rank
NZ$0.97 B
Marketcap
NZ$48.51
Share price
-3.12%
Change (1 day)
-20.35%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement